Pediatric herpes simplex of the anterior segment: Characteristics, treatment, and outcomes

Shaohui Liu, Deborah Pavan-Langston, Kathryn A. Colby

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: To describe the clinical characteristics, treatment, and outcomes of herpes simplex virus (HSV) infections of the cornea and adnexae to raise awareness and to improve management of this important eye disease in children. Design: Retrospective case series. Participants: Fifty-three patients (57 eyes) 16 years of age or younger with HSV keratitis (HSK), HSV blepharoconjunctivitis (HBC), or both in an academic cornea practice. Methods: The following data were collected: age at disease onset, putative trigger factors, coexisting systemic diseases, duration of symptoms and diagnoses given before presentation, visual acuity, slit-lamp examination findings, corneal sensation, dose and duration of medications used, drug side effects, and disease recurrence. Main Outcome Measures: Presence of residual corneal scarring, visual acuity at the last visit, changes in corneal sensation, recurrence rate, and manifestations of HSK were assessed in patients receiving long-term prophylactic systemic acyclovir. Results: The median age at onset was 5 years. Mean follow-up was 3.6 years. Eighteen eyes had HBC only; 4 patients in this group had bilateral disease. Of 39 eyes with keratitis, 74% had stromal disease. Thirty percent of HSK cases were misdiagnosed before presentation. Seventy-nine percent of patients with keratitis had corneal scarring and 26% had vision of 20/40 or worse at the last visit. Eighty percent of patients had recurrent disease. Six of 16 patients (37%) receiving long-term oral acyclovir had recurrent HSV, at least one case of which followed a growth spurt that caused the baseline dosage of acyclovir to become subtherapeutic. Conclusions: In a large series, pediatric HSK had a high rate of misdiagnosis, stromal involvement, recurrence, and vision loss. Oral acyclovir is effective, but the dosage must be adjusted as the child grows. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Original languageEnglish (US)
Pages (from-to)2003-2008
Number of pages6
JournalOphthalmology
Volume119
Issue number10
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Herpes Simplex
Keratitis
Acyclovir
Simplexvirus
Pediatrics
Diagnostic Errors
Age of Onset
Recurrence
Cornea
Visual Acuity
Cicatrix
Herpetic Keratitis
Eye Diseases
Disclosure
Virus Diseases
Drug-Related Side Effects and Adverse Reactions
Outcome Assessment (Health Care)
Growth

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Pediatric herpes simplex of the anterior segment : Characteristics, treatment, and outcomes. / Liu, Shaohui; Pavan-Langston, Deborah; Colby, Kathryn A.

In: Ophthalmology, Vol. 119, No. 10, 01.10.2012, p. 2003-2008.

Research output: Contribution to journalArticle

Liu, Shaohui ; Pavan-Langston, Deborah ; Colby, Kathryn A. / Pediatric herpes simplex of the anterior segment : Characteristics, treatment, and outcomes. In: Ophthalmology. 2012 ; Vol. 119, No. 10. pp. 2003-2008.
@article{9570962c45724d01b13570d98b91e178,
title = "Pediatric herpes simplex of the anterior segment: Characteristics, treatment, and outcomes",
abstract = "Purpose: To describe the clinical characteristics, treatment, and outcomes of herpes simplex virus (HSV) infections of the cornea and adnexae to raise awareness and to improve management of this important eye disease in children. Design: Retrospective case series. Participants: Fifty-three patients (57 eyes) 16 years of age or younger with HSV keratitis (HSK), HSV blepharoconjunctivitis (HBC), or both in an academic cornea practice. Methods: The following data were collected: age at disease onset, putative trigger factors, coexisting systemic diseases, duration of symptoms and diagnoses given before presentation, visual acuity, slit-lamp examination findings, corneal sensation, dose and duration of medications used, drug side effects, and disease recurrence. Main Outcome Measures: Presence of residual corneal scarring, visual acuity at the last visit, changes in corneal sensation, recurrence rate, and manifestations of HSK were assessed in patients receiving long-term prophylactic systemic acyclovir. Results: The median age at onset was 5 years. Mean follow-up was 3.6 years. Eighteen eyes had HBC only; 4 patients in this group had bilateral disease. Of 39 eyes with keratitis, 74{\%} had stromal disease. Thirty percent of HSK cases were misdiagnosed before presentation. Seventy-nine percent of patients with keratitis had corneal scarring and 26{\%} had vision of 20/40 or worse at the last visit. Eighty percent of patients had recurrent disease. Six of 16 patients (37{\%}) receiving long-term oral acyclovir had recurrent HSV, at least one case of which followed a growth spurt that caused the baseline dosage of acyclovir to become subtherapeutic. Conclusions: In a large series, pediatric HSK had a high rate of misdiagnosis, stromal involvement, recurrence, and vision loss. Oral acyclovir is effective, but the dosage must be adjusted as the child grows. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.",
author = "Shaohui Liu and Deborah Pavan-Langston and Colby, {Kathryn A.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.ophtha.2012.05.008",
language = "English (US)",
volume = "119",
pages = "2003--2008",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Pediatric herpes simplex of the anterior segment

T2 - Characteristics, treatment, and outcomes

AU - Liu, Shaohui

AU - Pavan-Langston, Deborah

AU - Colby, Kathryn A.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Purpose: To describe the clinical characteristics, treatment, and outcomes of herpes simplex virus (HSV) infections of the cornea and adnexae to raise awareness and to improve management of this important eye disease in children. Design: Retrospective case series. Participants: Fifty-three patients (57 eyes) 16 years of age or younger with HSV keratitis (HSK), HSV blepharoconjunctivitis (HBC), or both in an academic cornea practice. Methods: The following data were collected: age at disease onset, putative trigger factors, coexisting systemic diseases, duration of symptoms and diagnoses given before presentation, visual acuity, slit-lamp examination findings, corneal sensation, dose and duration of medications used, drug side effects, and disease recurrence. Main Outcome Measures: Presence of residual corneal scarring, visual acuity at the last visit, changes in corneal sensation, recurrence rate, and manifestations of HSK were assessed in patients receiving long-term prophylactic systemic acyclovir. Results: The median age at onset was 5 years. Mean follow-up was 3.6 years. Eighteen eyes had HBC only; 4 patients in this group had bilateral disease. Of 39 eyes with keratitis, 74% had stromal disease. Thirty percent of HSK cases were misdiagnosed before presentation. Seventy-nine percent of patients with keratitis had corneal scarring and 26% had vision of 20/40 or worse at the last visit. Eighty percent of patients had recurrent disease. Six of 16 patients (37%) receiving long-term oral acyclovir had recurrent HSV, at least one case of which followed a growth spurt that caused the baseline dosage of acyclovir to become subtherapeutic. Conclusions: In a large series, pediatric HSK had a high rate of misdiagnosis, stromal involvement, recurrence, and vision loss. Oral acyclovir is effective, but the dosage must be adjusted as the child grows. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

AB - Purpose: To describe the clinical characteristics, treatment, and outcomes of herpes simplex virus (HSV) infections of the cornea and adnexae to raise awareness and to improve management of this important eye disease in children. Design: Retrospective case series. Participants: Fifty-three patients (57 eyes) 16 years of age or younger with HSV keratitis (HSK), HSV blepharoconjunctivitis (HBC), or both in an academic cornea practice. Methods: The following data were collected: age at disease onset, putative trigger factors, coexisting systemic diseases, duration of symptoms and diagnoses given before presentation, visual acuity, slit-lamp examination findings, corneal sensation, dose and duration of medications used, drug side effects, and disease recurrence. Main Outcome Measures: Presence of residual corneal scarring, visual acuity at the last visit, changes in corneal sensation, recurrence rate, and manifestations of HSK were assessed in patients receiving long-term prophylactic systemic acyclovir. Results: The median age at onset was 5 years. Mean follow-up was 3.6 years. Eighteen eyes had HBC only; 4 patients in this group had bilateral disease. Of 39 eyes with keratitis, 74% had stromal disease. Thirty percent of HSK cases were misdiagnosed before presentation. Seventy-nine percent of patients with keratitis had corneal scarring and 26% had vision of 20/40 or worse at the last visit. Eighty percent of patients had recurrent disease. Six of 16 patients (37%) receiving long-term oral acyclovir had recurrent HSV, at least one case of which followed a growth spurt that caused the baseline dosage of acyclovir to become subtherapeutic. Conclusions: In a large series, pediatric HSK had a high rate of misdiagnosis, stromal involvement, recurrence, and vision loss. Oral acyclovir is effective, but the dosage must be adjusted as the child grows. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=84867098821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867098821&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2012.05.008

DO - 10.1016/j.ophtha.2012.05.008

M3 - Article

C2 - 22796308

AN - SCOPUS:84867098821

VL - 119

SP - 2003

EP - 2008

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 10

ER -